Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine: a phase III, randomized trial in adults aged ≥18 years
2013 · BMC Infectious Diseases · 103 citations
https://doi.org/10.1186/1471-2334-13-343